301207.SZ
Price:
$16.2
Market Cap:
$9.64B
Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a subsidiary of Hualan Biological Engineering Inc.
Industry
Biotechnology
IPO Date
2022-02-18
Stock Exchange
SHZ
Ticker
301207.SZ
According to Hualan Biological Bacterin Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.74. This represents a change of 9.73% compared to the average of 3.41 of the last 4 quarters.
The mean historical Current Ratio of Hualan Biological Bacterin Inc. over the last ten years is 2.41. The current 3.74 Current Ratio has changed 15.43% with respect to the historical average. Over the past ten years (40 quarters), 301207.SZ's Current Ratio was at its highest in in the March 2025 quarter at 3.74. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
2.41
Median
2.39
Minimum
1.51
Maximum
3.40
Discovering the peaks and valleys of Hualan Biological Bacterin Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 80.36%
Maximum Annual Current Ratio = 3.40
Minimum Annual Increase = -28.65%
Minimum Annual Current Ratio = 1.51
Year | Current Ratio | Change |
---|---|---|
2024 | 3.40 | 9.61% |
2023 | 3.10 | 13.67% |
2022 | 2.73 | 80.36% |
2021 | 1.51 | -10.76% |
2020 | 1.69 | -28.65% |
2019 | 2.38 | 15.63% |
2018 | 2.05 | -14.43% |
The current Current Ratio of Hualan Biological Bacterin Inc. (301207.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.08
5-year avg
2.49
10-year avg
2.41
Hualan Biological Bacterin Inc.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hualan Biological Bacterin Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hualan Biological Bacterin Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Hualan Biological Bacterin Inc.'s Current Ratio?
How is the Current Ratio calculated for Hualan Biological Bacterin Inc. (301207.SZ)?
What is the highest Current Ratio for Hualan Biological Bacterin Inc. (301207.SZ)?
What is the 3-year average Current Ratio for Hualan Biological Bacterin Inc. (301207.SZ)?
What is the 5-year average Current Ratio for Hualan Biological Bacterin Inc. (301207.SZ)?
How does the current Current Ratio for Hualan Biological Bacterin Inc. (301207.SZ) compare to its historical average?